istock-949432696-artur
Artur / iStockphoto.com
28 January 2019Americas

Merck signs DNA licensing deal with Vertex

German pharmaceutical company  Merck Group has granted US biotech firm  Vertex a licence to two DNA-dependent protein kinases (DNA-PK) inhibitors.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
13 December 2018   France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
Big Pharma
11 March 2019   King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.

More on this story

Big Pharma
13 December 2018   France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
Big Pharma
11 March 2019   King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.

More on this story

Big Pharma
13 December 2018   France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
Big Pharma
11 March 2019   King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.